Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 14, 2002

View Archived Issues

TRK-820 as a pharmacotherapeutic for cocaine addiction

A once-daily dose regimen of NN-2211 found to be feasible for NIDDM

Intimatan superior to dalteparin in canine model of vessel wall injury thrombosis

Bio-Technology General offers second-quarter progress report

Bicifadine as effective as codeine in treating moderate to severe postsurgical dental pain

Vitex and Pall modify Inactine collaboration

Phase III results for Provenge in prostate cancer

Enrollment completed in phase II HspE7 trial

Essential Therapeutics and Fujisawa collaborate on antibiotic drug discovery

Clearance given for FM-VP4 trial

Avanir and Medison sign research and marketing agreement for Neurodex in Israel

ANO-2, a novel cyclic peroxide, shows multifunctional antiangiogenic and antitumor activity

Doxycycline inhibits abdominal aortic aneurysm growth

FDA approves Eloxatin for advanced colorectal cancer

Proneuron expands recruitment in macrophage therapy phase I trial in spinal cord injury

INS-37217 Intranasal improves multiple perennial allergic rhinitis symptoms in phase II trial

AstraZeneca researchers identify new IBAT inhibitors for dyslipidemic conditions

New antibacterial and antiprotozoal compounds claimed by De Novo

Novel antirhinoviral compounds prepared and tested at Biota

Novel NMDA receptor antagonists disclosed in patent

Novel EGFR inhibitors in early development at Boehringer Ingelheim

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...